Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
株式のランク #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
株価
$0.00162013
最終同期: 2025-01-03
時価総額
$156.25K
変化(1日)
0.36%
変化(1年)
0.00%
SE
取引 Cyxone AB (publ) (CYXO)

カテゴリー

Cyxone AB (publ)(CYXO)の株価履歴
終値の最高値: $0.00 (2025-01-01)

終値の最安値: $0.50 (2016-06-01)
Cyxone AB (publ) の株価履歴(2016 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE